[Event Report] Third Forum: Public Understanding – Increasing Public Awareness and Understanding on the Impacts and Benefits of Cost-Effectiveness Assessment – (November 12, 2018)
date : 11/28/2018
Tags: Future of the Health Care System, Innovation and Sustainability
HGPI convened the Third Forum “Public Understanding – Increasing Public Awareness and Understanding on the Impacts and Benefits of Cost-Effectiveness Assessment -” on November 12, 2018.
Based on the issues raised at the preparatory meeting “Rebalancing Healthcare Systems: Innovation and Sustainability Series – Issues Identified from the Trial Introduction of Cost-Effectiveness Assessment” held on May 31, we identified three key themes (technical issues, issues for institutionalization, and public understanding) to be discussed in FY2018 and have been conducting a series of forums.
In this meeting, a roundtable discussion on Public Understanding on HTA was held with experts from industry, government, academia, and civil society. The discussions included policy functions required for the future implementation of Cost-Effectiveness Assessment, as well as its impact on the current healthcare and drug pricing systems.
The Final Symposium is scheduled as follows:
- Expert Meeting “The Future of Healthcare in Japan and Cost-Effective Assessment” (December 14, 2018)
Organizer: HGPI
Participants: Policymakers, representatives from the government, academia and private sectors
Opening (Explanatory introduction)
- Joji Sugawara (Associate, HGPI)
Roundtable Session “Public Understanding – Increasing Public Awareness and Understanding on the Impacts and Benefits of Cost-Effectiveness Assessment -“
Roundtable Speakers (Titles omitted, in Japanese syllabary order)
- Manabu Akazawa (Professor, Department of Public Health and Epidemiology, Meiji Pharmaceutical University)
- Mamoru Ichikawa (Principal Program Director, Production Center I Science Programs Division, Program Production Department, Japan Broadcasting Corporation (NHK))
- Sachie Inoue (Director, Crecon Medical Assessment Inc.)
- Satoshi Imamura (Vice-President, Japan Medical Association)
- Yoshie Onishi (Director, Japan Operations, Creativ-Ceutical K.K.)
- Kosuke Kato (Managing Director, Edwards Lifesciences Limited)
- Isao Kamae (Project Professor, Graduate School of Public Policy, the University of Tokyo)
- Yasushi Goto (Department of Respiratory Medicine, National Cancer Center Hospital)
- Shigekazu Komoto (Planning Officer, Medical Economics Division, Health Insurance Bureau, Ministry of Health, Labour and Welfare (MHLW))
- Naomi Sakurai (President, Cancer Solutions Co., Ltd.)
- Toshio Nagase (Director, Government Affairs, Gilead Science K.K.)
- Hiroshi Nakamura (Professor, Graduate School of Business Administration, Keio University)
- Takashi Fukuda (Director, Department of Health and Welfare Service, National Institution of Public health)
- Yoshiyuki Majima (President, Pancreatic Cancer Action Network Japan)
Moderator
- Joji Sugawara (Associate, HGPI)
Since 2016, HGPI has conducted a series of expert meetings entitled “Rebalancing Healthcare Systems: Innovation and Sustainability” to facilitate open discussions on HTA. Throughout these meetings, we have worked to identify the issues and to provide policy recommendations. For the past activities, please refer to the “Activity Report – Special Edition on Innovation and Sustainability” (attached below).
日本語
Top Research & Recommendations Posts
- [Report and Recommendations] Discussion Points in Healthcare DX Project Expert Panel Meeting (April 2, 2024)
- [Event Report] Planetary Health Expert Meeting Aiming for Sustainable Healthcare: Learning from the Impact of Environmental Pollution and Medical Waste During the Pandemic (February 16, 2024)
- [Announcement] A Significant Step Towards the Building a Green Healthcare System: Support for the Formal Expression of Interest by the Japanese Government Delegation to the ATACH at the Executive Board Meeting of the WHO (February 16, 2024)
- [Policy Recommendations] Kidney Disease Control Promotion Project 2023 “Establishing Kidney Disease Control Measures with Patient, Citizen, and Community Engagement and Collaboration” Policy Recommendations, a Collection of Good Practices of Chronic Kidney Disease (CKD) and Control Measures in Local Governments (February 14, 2024)
- [Research Report] Building a Mental Health Program for Children and Measuring its Effectiveness (June 16, 2022)
- [Research Report] 2019 Survey on Healthcare in Japan
- [Research Report] Survey of Japanese Physicians Regarding Climate Change and Health (December 3, 2023)
- [Policy Recommendations] Dementia Prevention Initiatives for Achieving a Dementia-Friendly and Inclusive Society (March 26, 2024)
- [Announcement] HGPI Joins Global Climate and Health Alliance (March 23, 2024)
- [Publication Report] Developing and Expanding Cardiovascular Disease Control Plans in Each Prefecture – Challenges and Good Examples for Cardiovascular Disease Control (September 7, 2023)
Featured Posts
-
2024-04-12
[Announcement] HGPI Joins Global Climate and Health Alliance (March 23, 2024)
-
2024-04-16
[Activity Report] HGPI Child Health Project Selected to Implement FY2024 Nippon Foundation Grant Program, “Establishing a Skill Development Program and Collaborative Network for Improving Mental Health for Students with Intellectual Disabilities” (April 15, 2024)
-
2024-04-18
[Event Report] NCDs-related Cross-project Meeting: The 2nd Meeting on Non-Communicable Disease in Hokkaido and Tohoku (March 15, 2024)
-
2024-04-23
[Registration Open] The 125th HGPI Seminar: Progress and Prospects for Domestic Measures on Health Problems Caused by Alcohol (May 24 , 2024)